tirzepatide phase 3 study results FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes A 3-year study of tirzepatide
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1





























